# A Phase 1 Study to Evaluate the Effect of Food on Pharmacokinetics of ASTX029

> **NCT04466514** · PHASE1 · COMPLETED · sponsor: **Astex Pharmaceuticals, Inc.** · enrollment: 18 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** ASTX029

## Key facts

- **NCT ID:** NCT04466514
- **Lead sponsor:** Astex Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-23
- **Primary completion:** 2020-10-01
- **Final completion:** 2020-10-06
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2024-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04466514

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04466514, "A Phase 1 Study to Evaluate the Effect of Food on Pharmacokinetics of ASTX029". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT04466514. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*